Browsing by Author "Abdelwahed Gaber M."
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
Item Evaluation of the effect and mechanism of action of local phenytoin in treatment of vitiligo(Taylor and Francis Inc., 2017) Abdou A.G.; Abdelwahed Gaber M.; Elnaidany N.F.; Elnagar A.; Pathology Department; Faculty of Medicine; Menoufia University; Shebein Elkom; Egypt; Dermatology Department; Faculty of Medicine; Menoufia University; Shebein Elkom; Egypt; Clinical Pharmacy Department; MSA October University; Cairo; EgyptThere are many theories explaining vitiligo such as genetic, autoimmune, neural, free radicals, biochemical, intrinsic defect, melanocytorrhagy, and convergent theories. Phenytoin is a widely used anticonvulsant, which is used in cutaneous medicine for treatment of ulcers and epidermolysis bullosa. The aim of this study is to assess the effectiveness of topical phenytoin gel in the treatment of vitiligo patients and explaining the underlying mechanism using immunohistochemistry for evaluation of HMB45, CD4, and CD8. Only 9 patients out of 28 experienced response to phenytoin in the form of dull, white color change and light brown color. Post-phenytoin treatment biopsies showed decreased density of inflammation, increased melanin and increased HMB45 positive cells together with an increased number of CD4 positive lymphocytes and decreased number of CD8 positive lymphocytes. These observations did not reach significant level (P > 0.05). A high percentage of CD4 positive lymphocytes was significantly associated with a long duration of vitiligo (p = 0.03) and segmental vitiligo type (p = 0.02). The current study applied phenytoin as 2% concentrated gel for 3 months, which is a relatively short duration without observed side effects throughout the period. These results indicate that topical phenytoin of low concentrations may have beneficial effects through immunomodulatory activity by affecting CD4 and CD8 counts and subsequently the ratio between them. Further studies are recommended to combine phenytoin with other antivitiligo agents as local corticosteroids or phototherapy to clarify if it could potentiate their effects. � 2017 Taylor & Francis.